The drug diABZI – which activates the body’s innate immune response – was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses.
Penn researchers discover drug that blocks multiple SARS-CoV-2 variants in mice
May 31, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022